nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—colon cancer	0.335	1	CbGaD
Mifepristone—ABCC1—Irinotecan—colon cancer	0.0903	0.172	CbGbCtD
Mifepristone—ABCC1—Vincristine—colon cancer	0.0789	0.151	CbGbCtD
Mifepristone—ABCC1—Methotrexate—colon cancer	0.0478	0.0912	CbGbCtD
Mifepristone—CYP3A7—Irinotecan—colon cancer	0.0446	0.0852	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0446	0.0852	CbGbCtD
Mifepristone—CYP3A7—Vincristine—colon cancer	0.039	0.0745	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.039	0.0745	CbGbCtD
Mifepristone—CYP3A5—Irinotecan—colon cancer	0.0335	0.0639	CbGbCtD
Mifepristone—CYP3A5—Vincristine—colon cancer	0.0293	0.0559	CbGbCtD
Mifepristone—ABCB1—Irinotecan—colon cancer	0.0218	0.0416	CbGbCtD
Mifepristone—ABCB1—Vincristine—colon cancer	0.019	0.0364	CbGbCtD
Mifepristone—CYP3A4—Irinotecan—colon cancer	0.0131	0.0249	CbGbCtD
Mifepristone—ABCB1—Methotrexate—colon cancer	0.0115	0.022	CbGbCtD
Mifepristone—AR—scrotum—colon cancer	0.0115	0.288	CbGeAlD
Mifepristone—CYP3A4—Vincristine—colon cancer	0.0114	0.0218	CbGbCtD
Mifepristone—PGR—blood vessel—colon cancer	0.00235	0.0588	CbGeAlD
Mifepristone—Blood potassium decreased—Capecitabine—colon cancer	0.00153	0.0255	CcSEcCtD
Mifepristone—PGR—epithelium—colon cancer	0.00115	0.0286	CbGeAlD
Mifepristone—PGR—smooth muscle tissue—colon cancer	0.0011	0.0276	CbGeAlD
Mifepristone—CYP3A7—liver—colon cancer	0.00107	0.0268	CbGeAlD
Mifepristone—AR—epithelium—colon cancer	0.000913	0.0228	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—liver—colon cancer	0.000912	0.0228	CbGeAlD
Mifepristone—Blood triglycerides increased—Capecitabine—colon cancer	0.00089	0.0148	CcSEcCtD
Mifepristone—PGR—lymphoid tissue—colon cancer	0.000882	0.0221	CbGeAlD
Mifepristone—AR—smooth muscle tissue—colon cancer	0.000879	0.022	CbGeAlD
Mifepristone—AR—renal system—colon cancer	0.000847	0.0212	CbGeAlD
Mifepristone—Metrorrhagia—Capecitabine—colon cancer	0.000817	0.0136	CcSEcCtD
Mifepristone—NR3C1—embryo—colon cancer	0.00081	0.0203	CbGeAlD
Mifepristone—Vaginal haemorrhage—Capecitabine—colon cancer	0.000788	0.0131	CcSEcCtD
Mifepristone—PGR—vagina—colon cancer	0.00077	0.0192	CbGeAlD
Mifepristone—Rash maculo-papular—Fluorouracil—colon cancer	0.000759	0.0126	CcSEcCtD
Mifepristone—ABCB1—blood vessel—colon cancer	0.000727	0.0182	CbGeAlD
Mifepristone—AR—lymphoid tissue—colon cancer	0.000703	0.0176	CbGeAlD
Mifepristone—AR—digestive system—colon cancer	0.000694	0.0174	CbGeAlD
Mifepristone—Dermatitis exfoliative—Irinotecan—colon cancer	0.000671	0.0111	CcSEcCtD
Mifepristone—NR3C1—epithelium—colon cancer	0.000661	0.0165	CbGeAlD
Mifepristone—Pain in extremity—Vincristine—colon cancer	0.00065	0.0108	CcSEcCtD
Mifepristone—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.000646	0.0107	CcSEcCtD
Mifepristone—NR3C1—smooth muscle tissue—colon cancer	0.000637	0.0159	CbGeAlD
Mifepristone—CYP3A5—renal system—colon cancer	0.000618	0.0154	CbGeAlD
Mifepristone—AR—vagina—colon cancer	0.000613	0.0153	CbGeAlD
Mifepristone—NR3C1—renal system—colon cancer	0.000613	0.0153	CbGeAlD
Mifepristone—ABCC1—vagina—colon cancer	0.000582	0.0146	CbGeAlD
Mifepristone—Hypokalaemia—Irinotecan—colon cancer	0.000576	0.00957	CcSEcCtD
Mifepristone—Muscular weakness—Vincristine—colon cancer	0.000573	0.00952	CcSEcCtD
Mifepristone—Cramp muscle—Irinotecan—colon cancer	0.00057	0.00947	CcSEcCtD
Mifepristone—Nasopharyngitis—Fluorouracil—colon cancer	0.000542	0.00901	CcSEcCtD
Mifepristone—Muscular weakness—Fluorouracil—colon cancer	0.000535	0.00888	CcSEcCtD
Mifepristone—AR—liver—colon cancer	0.000517	0.0129	CbGeAlD
Mifepristone—NR3C1—lymphoid tissue—colon cancer	0.000509	0.0127	CbGeAlD
Mifepristone—CYP3A5—digestive system—colon cancer	0.000507	0.0127	CbGeAlD
Mifepristone—NR3C1—digestive system—colon cancer	0.000503	0.0126	CbGeAlD
Mifepristone—PGR—lymph node—colon cancer	0.000498	0.0124	CbGeAlD
Mifepristone—ABCC1—liver—colon cancer	0.000491	0.0123	CbGeAlD
Mifepristone—Infestation—Fluorouracil—colon cancer	0.000467	0.00776	CcSEcCtD
Mifepristone—Infestation NOS—Fluorouracil—colon cancer	0.000467	0.00776	CcSEcCtD
Mifepristone—CYP3A4—renal system—colon cancer	0.000464	0.0116	CbGeAlD
Mifepristone—NR3C1—bone marrow—colon cancer	0.000464	0.0116	CbGeAlD
Mifepristone—CYP2D6—renal system—colon cancer	0.000456	0.0114	CbGeAlD
Mifepristone—Hot flush—Capecitabine—colon cancer	0.000453	0.00752	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Capecitabine—colon cancer	0.000449	0.00746	CcSEcCtD
Mifepristone—Menopausal symptoms—Capecitabine—colon cancer	0.000449	0.00746	CcSEcCtD
Mifepristone—CYP3A5—vagina—colon cancer	0.000448	0.0112	CbGeAlD
Mifepristone—Thirst—Capecitabine—colon cancer	0.000445	0.0074	CcSEcCtD
Mifepristone—NR3C1—vagina—colon cancer	0.000444	0.0111	CbGeAlD
Mifepristone—Connective tissue disorder—Vincristine—colon cancer	0.000442	0.00734	CcSEcCtD
Mifepristone—Haemoglobin—Irinotecan—colon cancer	0.00044	0.00731	CcSEcCtD
Mifepristone—Sinusitis—Fluorouracil—colon cancer	0.000438	0.00728	CcSEcCtD
Mifepristone—Haemorrhage—Irinotecan—colon cancer	0.000438	0.00727	CcSEcCtD
Mifepristone—ABCB1—embryo—colon cancer	0.000434	0.0108	CbGeAlD
Mifepristone—Connective tissue disorder—Irinotecan—colon cancer	0.00043	0.00715	CcSEcCtD
Mifepristone—Pain in extremity—Capecitabine—colon cancer	0.000424	0.00704	CcSEcCtD
Mifepristone—Haemoglobin—Fluorouracil—colon cancer	0.000421	0.007	CcSEcCtD
Mifepristone—Haemorrhage—Fluorouracil—colon cancer	0.000419	0.00697	CcSEcCtD
Mifepristone—Angiopathy—Vincristine—colon cancer	0.000408	0.00678	CcSEcCtD
Mifepristone—Mediastinal disorder—Vincristine—colon cancer	0.000405	0.00673	CcSEcCtD
Mifepristone—Angiopathy—Irinotecan—colon cancer	0.000397	0.0066	CcSEcCtD
Mifepristone—AR—lymph node—colon cancer	0.000397	0.00992	CbGeAlD
Mifepristone—Mediastinal disorder—Irinotecan—colon cancer	0.000395	0.00656	CcSEcCtD
Mifepristone—Mental disorder—Vincristine—colon cancer	0.000394	0.00654	CcSEcCtD
Mifepristone—Chills—Irinotecan—colon cancer	0.000393	0.00653	CcSEcCtD
Mifepristone—Hypokalaemia—Capecitabine—colon cancer	0.000385	0.00641	CcSEcCtD
Mifepristone—Breast disorder—Capecitabine—colon cancer	0.000383	0.00636	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000381	0.00634	CcSEcCtD
Mifepristone—CYP3A4—digestive system—colon cancer	0.00038	0.00951	CbGeAlD
Mifepristone—Nasopharyngitis—Capecitabine—colon cancer	0.000379	0.00629	CcSEcCtD
Mifepristone—Back pain—Vincristine—colon cancer	0.000379	0.00629	CcSEcCtD
Mifepristone—CYP3A5—liver—colon cancer	0.000378	0.00944	CbGeAlD
Mifepristone—ABCC1—lymph node—colon cancer	0.000377	0.00942	CbGeAlD
Mifepristone—NR3C1—liver—colon cancer	0.000375	0.00937	CbGeAlD
Mifepristone—CYP2D6—digestive system—colon cancer	0.000374	0.00936	CbGeAlD
Mifepristone—Muscular weakness—Capecitabine—colon cancer	0.000374	0.00621	CcSEcCtD
Mifepristone—Back pain—Irinotecan—colon cancer	0.000369	0.00613	CcSEcCtD
Mifepristone—Muscle spasms—Irinotecan—colon cancer	0.000366	0.00609	CcSEcCtD
Mifepristone—ABCB1—epithelium—colon cancer	0.000354	0.00885	CbGeAlD
Mifepristone—Ill-defined disorder—Irinotecan—colon cancer	0.000354	0.00588	CcSEcCtD
Mifepristone—Malaise—Irinotecan—colon cancer	0.000344	0.00571	CcSEcCtD
Mifepristone—Hypertension—Vincristine—colon cancer	0.000338	0.00561	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—colon cancer	0.000334	0.00555	CcSEcCtD
Mifepristone—Myalgia—Vincristine—colon cancer	0.000333	0.00554	CcSEcCtD
Mifepristone—Hypertension—Irinotecan—colon cancer	0.000329	0.00547	CcSEcCtD
Mifepristone—ABCB1—renal system—colon cancer	0.000328	0.00821	CbGeAlD
Mifepristone—Infestation NOS—Capecitabine—colon cancer	0.000326	0.00542	CcSEcCtD
Mifepristone—Infestation—Capecitabine—colon cancer	0.000326	0.00542	CcSEcCtD
Mifepristone—Discomfort—Irinotecan—colon cancer	0.000321	0.00533	CcSEcCtD
Mifepristone—Oedema—Vincristine—colon cancer	0.000319	0.00531	CcSEcCtD
Mifepristone—Infection—Vincristine—colon cancer	0.000317	0.00527	CcSEcCtD
Mifepristone—Nervous system disorder—Vincristine—colon cancer	0.000313	0.0052	CcSEcCtD
Mifepristone—Oedema—Irinotecan—colon cancer	0.000311	0.00517	CcSEcCtD
Mifepristone—Myalgia—Fluorouracil—colon cancer	0.000311	0.00516	CcSEcCtD
Mifepristone—Infection—Irinotecan—colon cancer	0.000309	0.00513	CcSEcCtD
Mifepristone—Discomfort—Fluorouracil—colon cancer	0.000307	0.0051	CcSEcCtD
Mifepristone—Nervous system disorder—Irinotecan—colon cancer	0.000305	0.00507	CcSEcCtD
Mifepristone—Anorexia—Vincristine—colon cancer	0.000304	0.00506	CcSEcCtD
Mifepristone—Hypotension—Vincristine—colon cancer	0.000298	0.00496	CcSEcCtD
Mifepristone—Oedema—Fluorouracil—colon cancer	0.000298	0.00495	CcSEcCtD
Mifepristone—Anorexia—Irinotecan—colon cancer	0.000296	0.00493	CcSEcCtD
Mifepristone—Infection—Fluorouracil—colon cancer	0.000296	0.00492	CcSEcCtD
Mifepristone—Haemoglobin—Capecitabine—colon cancer	0.000294	0.00489	CcSEcCtD
Mifepristone—Haemorrhage—Capecitabine—colon cancer	0.000293	0.00487	CcSEcCtD
Mifepristone—Nervous system disorder—Fluorouracil—colon cancer	0.000292	0.00485	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000291	0.00484	CcSEcCtD
Mifepristone—Hypotension—Irinotecan—colon cancer	0.000291	0.00483	CcSEcCtD
Mifepristone—Insomnia—Vincristine—colon cancer	0.000289	0.0048	CcSEcCtD
Mifepristone—Oedema peripheral—Capecitabine—colon cancer	0.000289	0.0048	CcSEcCtD
Mifepristone—Connective tissue disorder—Capecitabine—colon cancer	0.000288	0.00478	CcSEcCtD
Mifepristone—NR3C1—lymph node—colon cancer	0.000287	0.00718	CbGeAlD
Mifepristone—Breast disorder—Methotrexate—colon cancer	0.000285	0.00473	CcSEcCtD
Mifepristone—Anorexia—Fluorouracil—colon cancer	0.000284	0.00472	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000284	0.00472	CcSEcCtD
Mifepristone—CYP3A4—liver—colon cancer	0.000283	0.00708	CbGeAlD
Mifepristone—Insomnia—Irinotecan—colon cancer	0.000281	0.00467	CcSEcCtD
Mifepristone—CYP2D6—liver—colon cancer	0.000279	0.00697	CbGeAlD
Mifepristone—Hypotension—Fluorouracil—colon cancer	0.000278	0.00463	CcSEcCtD
Mifepristone—Decreased appetite—Vincristine—colon cancer	0.000278	0.00461	CcSEcCtD
Mifepristone—Dyspnoea—Irinotecan—colon cancer	0.000277	0.00461	CcSEcCtD
Mifepristone—Somnolence—Irinotecan—colon cancer	0.000276	0.00459	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Vincristine—colon cancer	0.000276	0.00458	CcSEcCtD
Mifepristone—Fatigue—Vincristine—colon cancer	0.000275	0.00458	CcSEcCtD
Mifepristone—Pain—Vincristine—colon cancer	0.000273	0.00454	CcSEcCtD
Mifepristone—Constipation—Vincristine—colon cancer	0.000273	0.00454	CcSEcCtD
Mifepristone—ABCB1—lymphoid tissue—colon cancer	0.000273	0.00681	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000271	0.00451	CcSEcCtD
Mifepristone—Decreased appetite—Irinotecan—colon cancer	0.00027	0.00449	CcSEcCtD
Mifepristone—Insomnia—Fluorouracil—colon cancer	0.000269	0.00448	CcSEcCtD
Mifepristone—ABCB1—digestive system—colon cancer	0.000269	0.00673	CbGeAlD
Mifepristone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000269	0.00446	CcSEcCtD
Mifepristone—Fatigue—Irinotecan—colon cancer	0.000268	0.00446	CcSEcCtD
Mifepristone—Pain—Irinotecan—colon cancer	0.000266	0.00442	CcSEcCtD
Mifepristone—Constipation—Irinotecan—colon cancer	0.000266	0.00442	CcSEcCtD
Mifepristone—Angiopathy—Capecitabine—colon cancer	0.000266	0.00442	CcSEcCtD
Mifepristone—Dyspnoea—Fluorouracil—colon cancer	0.000266	0.00441	CcSEcCtD
Mifepristone—Somnolence—Fluorouracil—colon cancer	0.000265	0.0044	CcSEcCtD
Mifepristone—Mediastinal disorder—Capecitabine—colon cancer	0.000264	0.00439	CcSEcCtD
Mifepristone—Chills—Capecitabine—colon cancer	0.000263	0.00437	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vincristine—colon cancer	0.000261	0.00434	CcSEcCtD
Mifepristone—Decreased appetite—Fluorouracil—colon cancer	0.000259	0.0043	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000257	0.00427	CcSEcCtD
Mifepristone—Mental disorder—Capecitabine—colon cancer	0.000257	0.00427	CcSEcCtD
Mifepristone—Feeling abnormal—Irinotecan—colon cancer	0.000256	0.00426	CcSEcCtD
Mifepristone—Malnutrition—Capecitabine—colon cancer	0.000255	0.00424	CcSEcCtD
Mifepristone—Pain—Fluorouracil—colon cancer	0.000255	0.00423	CcSEcCtD
Mifepristone—Gastrointestinal pain—Irinotecan—colon cancer	0.000254	0.00423	CcSEcCtD
Mifepristone—Abdominal pain—Vincristine—colon cancer	0.000252	0.0042	CcSEcCtD
Mifepristone—Body temperature increased—Vincristine—colon cancer	0.000252	0.0042	CcSEcCtD
Mifepristone—ABCB1—bone marrow—colon cancer	0.000248	0.00621	CbGeAlD
Mifepristone—Back pain—Capecitabine—colon cancer	0.000247	0.0041	CcSEcCtD
Mifepristone—Abdominal pain—Irinotecan—colon cancer	0.000246	0.00409	CcSEcCtD
Mifepristone—Body temperature increased—Irinotecan—colon cancer	0.000246	0.00409	CcSEcCtD
Mifepristone—Feeling abnormal—Fluorouracil—colon cancer	0.000245	0.00408	CcSEcCtD
Mifepristone—Muscle spasms—Capecitabine—colon cancer	0.000245	0.00408	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—colon cancer	0.000243	0.00404	CcSEcCtD
Mifepristone—Infestation—Methotrexate—colon cancer	0.000243	0.00404	CcSEcCtD
Mifepristone—ABCB1—vagina—colon cancer	0.000238	0.00594	CbGeAlD
Mifepristone—Ill-defined disorder—Capecitabine—colon cancer	0.000237	0.00393	CcSEcCtD
Mifepristone—Urticaria—Fluorouracil—colon cancer	0.000237	0.00393	CcSEcCtD
Mifepristone—Body temperature increased—Fluorouracil—colon cancer	0.000235	0.00391	CcSEcCtD
Mifepristone—Hypersensitivity—Vincristine—colon cancer	0.000235	0.00391	CcSEcCtD
Mifepristone—Malaise—Capecitabine—colon cancer	0.00023	0.00382	CcSEcCtD
Mifepristone—Hypersensitivity—Irinotecan—colon cancer	0.000229	0.00381	CcSEcCtD
Mifepristone—Asthenia—Vincristine—colon cancer	0.000229	0.00381	CcSEcCtD
Mifepristone—Asthenia—Irinotecan—colon cancer	0.000223	0.00371	CcSEcCtD
Mifepristone—Hypertension—Capecitabine—colon cancer	0.00022	0.00366	CcSEcCtD
Mifepristone—Hypersensitivity—Fluorouracil—colon cancer	0.000219	0.00365	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—colon cancer	0.000219	0.00364	CcSEcCtD
Mifepristone—Diarrhoea—Vincristine—colon cancer	0.000219	0.00363	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—colon cancer	0.000218	0.00362	CcSEcCtD
Mifepristone—Myalgia—Capecitabine—colon cancer	0.000217	0.00361	CcSEcCtD
Mifepristone—Arthralgia—Capecitabine—colon cancer	0.000217	0.00361	CcSEcCtD
Mifepristone—Anxiety—Capecitabine—colon cancer	0.000216	0.0036	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000216	0.00358	CcSEcCtD
Mifepristone—Discomfort—Capecitabine—colon cancer	0.000215	0.00357	CcSEcCtD
Mifepristone—Diarrhoea—Irinotecan—colon cancer	0.000213	0.00354	CcSEcCtD
Mifepristone—Dry mouth—Capecitabine—colon cancer	0.000212	0.00353	CcSEcCtD
Mifepristone—Dizziness—Vincristine—colon cancer	0.000211	0.00351	CcSEcCtD
Mifepristone—Pruritus—Fluorouracil—colon cancer	0.000211	0.0035	CcSEcCtD
Mifepristone—Oedema—Capecitabine—colon cancer	0.000208	0.00346	CcSEcCtD
Mifepristone—Infection—Capecitabine—colon cancer	0.000207	0.00344	CcSEcCtD
Mifepristone—Dizziness—Irinotecan—colon cancer	0.000206	0.00342	CcSEcCtD
Mifepristone—Nervous system disorder—Capecitabine—colon cancer	0.000204	0.00339	CcSEcCtD
Mifepristone—Diarrhoea—Fluorouracil—colon cancer	0.000204	0.00339	CcSEcCtD
Mifepristone—Vomiting—Vincristine—colon cancer	0.000203	0.00337	CcSEcCtD
Mifepristone—Skin disorder—Capecitabine—colon cancer	0.000202	0.00336	CcSEcCtD
Mifepristone—Rash—Vincristine—colon cancer	0.000201	0.00335	CcSEcCtD
Mifepristone—Dermatitis—Vincristine—colon cancer	0.000201	0.00334	CcSEcCtD
Mifepristone—ABCB1—liver—colon cancer	0.000201	0.00501	CbGeAlD
Mifepristone—Headache—Vincristine—colon cancer	0.0002	0.00332	CcSEcCtD
Mifepristone—Anorexia—Capecitabine—colon cancer	0.000198	0.0033	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—colon cancer	0.000198	0.00329	CcSEcCtD
Mifepristone—Vomiting—Irinotecan—colon cancer	0.000198	0.00329	CcSEcCtD
Mifepristone—Dizziness—Fluorouracil—colon cancer	0.000197	0.00327	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—colon cancer	0.000197	0.00327	CcSEcCtD
Mifepristone—Rash—Irinotecan—colon cancer	0.000196	0.00326	CcSEcCtD
Mifepristone—Dermatitis—Irinotecan—colon cancer	0.000196	0.00326	CcSEcCtD
Mifepristone—Chills—Methotrexate—colon cancer	0.000196	0.00325	CcSEcCtD
Mifepristone—Headache—Irinotecan—colon cancer	0.000195	0.00324	CcSEcCtD
Mifepristone—Hypotension—Capecitabine—colon cancer	0.000195	0.00323	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—colon cancer	0.000191	0.00318	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—colon cancer	0.00019	0.00316	CcSEcCtD
Mifepristone—Nausea—Vincristine—colon cancer	0.00019	0.00315	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00019	0.00315	CcSEcCtD
Mifepristone—Vomiting—Fluorouracil—colon cancer	0.000189	0.00315	CcSEcCtD
Mifepristone—Insomnia—Capecitabine—colon cancer	0.000188	0.00313	CcSEcCtD
Mifepristone—Rash—Fluorouracil—colon cancer	0.000188	0.00312	CcSEcCtD
Mifepristone—Dermatitis—Fluorouracil—colon cancer	0.000188	0.00312	CcSEcCtD
Mifepristone—Headache—Fluorouracil—colon cancer	0.000187	0.0031	CcSEcCtD
Mifepristone—Dyspnoea—Capecitabine—colon cancer	0.000186	0.00308	CcSEcCtD
Mifepristone—Nausea—Irinotecan—colon cancer	0.000185	0.00307	CcSEcCtD
Mifepristone—Back pain—Methotrexate—colon cancer	0.000184	0.00305	CcSEcCtD
Mifepristone—Decreased appetite—Capecitabine—colon cancer	0.000181	0.00301	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00018	0.00299	CcSEcCtD
Mifepristone—Fatigue—Capecitabine—colon cancer	0.000179	0.00298	CcSEcCtD
Mifepristone—Constipation—Capecitabine—colon cancer	0.000178	0.00296	CcSEcCtD
Mifepristone—Pain—Capecitabine—colon cancer	0.000178	0.00296	CcSEcCtD
Mifepristone—Nausea—Fluorouracil—colon cancer	0.000177	0.00294	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—colon cancer	0.000176	0.00293	CcSEcCtD
Mifepristone—Feeling abnormal—Capecitabine—colon cancer	0.000172	0.00285	CcSEcCtD
Mifepristone—Malaise—Methotrexate—colon cancer	0.000171	0.00285	CcSEcCtD
Mifepristone—Gastrointestinal pain—Capecitabine—colon cancer	0.00017	0.00283	CcSEcCtD
Mifepristone—Urticaria—Capecitabine—colon cancer	0.000165	0.00275	CcSEcCtD
Mifepristone—Abdominal pain—Capecitabine—colon cancer	0.000165	0.00273	CcSEcCtD
Mifepristone—Body temperature increased—Capecitabine—colon cancer	0.000165	0.00273	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—colon cancer	0.000162	0.00269	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—colon cancer	0.000162	0.00269	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000161	0.00267	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—colon cancer	0.00016	0.00265	CcSEcCtD
Mifepristone—Infection—Methotrexate—colon cancer	0.000154	0.00256	CcSEcCtD
Mifepristone—ABCB1—lymph node—colon cancer	0.000154	0.00384	CbGeAlD
Mifepristone—Hypersensitivity—Capecitabine—colon cancer	0.000153	0.00255	CcSEcCtD
Mifepristone—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.000152	0.00372	CbGpPWpGaD
Mifepristone—Nervous system disorder—Methotrexate—colon cancer	0.000152	0.00253	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—colon cancer	0.000151	0.0025	CcSEcCtD
Mifepristone—Asthenia—Capecitabine—colon cancer	0.000149	0.00248	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—colon cancer	0.000148	0.00245	CcSEcCtD
Mifepristone—Pruritus—Capecitabine—colon cancer	0.000147	0.00245	CcSEcCtD
Mifepristone—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.000147	0.00359	CbGpPWpGaD
Mifepristone—Hypotension—Methotrexate—colon cancer	0.000145	0.00241	CcSEcCtD
Mifepristone—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000142	0.00348	CbGpPWpGaD
Mifepristone—Diarrhoea—Capecitabine—colon cancer	0.000142	0.00237	CcSEcCtD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000142	0.00347	CbGpPWpGaD
Mifepristone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000141	0.00235	CcSEcCtD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000141	0.00344	CbGpPWpGaD
Mifepristone—Insomnia—Methotrexate—colon cancer	0.00014	0.00233	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—colon cancer	0.000138	0.0023	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—colon cancer	0.000138	0.00229	CcSEcCtD
Mifepristone—Dizziness—Capecitabine—colon cancer	0.000138	0.00229	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—colon cancer	0.000135	0.00224	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000134	0.00222	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—colon cancer	0.000134	0.00222	CcSEcCtD
Mifepristone—Pain—Methotrexate—colon cancer	0.000133	0.0022	CcSEcCtD
Mifepristone—Vomiting—Capecitabine—colon cancer	0.000132	0.0022	CcSEcCtD
Mifepristone—Rash—Capecitabine—colon cancer	0.000131	0.00218	CcSEcCtD
Mifepristone—Dermatitis—Capecitabine—colon cancer	0.000131	0.00218	CcSEcCtD
Mifepristone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000131	0.0032	CbGpPWpGaD
Mifepristone—Headache—Capecitabine—colon cancer	0.00013	0.00217	CcSEcCtD
Mifepristone—PGR—Generic Transcription Pathway—HNF4A—colon cancer	0.00013	0.00319	CbGpPWpGaD
Mifepristone—Feeling abnormal—Methotrexate—colon cancer	0.000128	0.00212	CcSEcCtD
Mifepristone—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000127	0.00311	CbGpPWpGaD
Mifepristone—Gastrointestinal pain—Methotrexate—colon cancer	0.000127	0.00211	CcSEcCtD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000125	0.00305	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000125	0.00305	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CA7—colon cancer	0.000124	0.00304	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.000124	0.00303	CbGpPWpGaD
Mifepristone—Nausea—Capecitabine—colon cancer	0.000124	0.00205	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—colon cancer	0.000123	0.00205	CcSEcCtD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.000123	0.003	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000123	0.003	CbGpPWpGaD
Mifepristone—Body temperature increased—Methotrexate—colon cancer	0.000122	0.00204	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—colon cancer	0.000122	0.00204	CcSEcCtD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.00012	0.00294	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000119	0.0029	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000118	0.00289	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.000117	0.00286	CbGpPWpGaD
Mifepristone—NR3C1—Circadian Clock—EP300—colon cancer	0.000117	0.00285	CbGpPWpGaD
Mifepristone—Hypersensitivity—Methotrexate—colon cancer	0.000114	0.0019	CcSEcCtD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.000114	0.00279	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.000114	0.00278	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000113	0.00276	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.000113	0.00275	CbGpPWpGaD
Mifepristone—Asthenia—Methotrexate—colon cancer	0.000111	0.00185	CcSEcCtD
Mifepristone—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.00011	0.00269	CbGpPWpGaD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.00011	0.00268	CbGpPWpGaD
Mifepristone—Pruritus—Methotrexate—colon cancer	0.00011	0.00182	CcSEcCtD
Mifepristone—CYP3A7—Metabolism—CA7—colon cancer	0.000108	0.00265	CbGpPWpGaD
Mifepristone—Diarrhoea—Methotrexate—colon cancer	0.000106	0.00176	CcSEcCtD
Mifepristone—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	0.000106	0.00259	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.000105	0.00256	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	0.000105	0.00255	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000103	0.00253	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DLC1—colon cancer	0.000103	0.00251	CbGpPWpGaD
Mifepristone—Dizziness—Methotrexate—colon cancer	0.000102	0.0017	CcSEcCtD
Mifepristone—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000102	0.00249	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.000102	0.00249	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	9.99e-05	0.00244	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—HNF4A—colon cancer	9.93e-05	0.00243	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	9.93e-05	0.00243	CbGpPWpGaD
Mifepristone—Vomiting—Methotrexate—colon cancer	9.85e-05	0.00164	CcSEcCtD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	9.83e-05	0.0024	CbGpPWpGaD
Mifepristone—Rash—Methotrexate—colon cancer	9.77e-05	0.00162	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—colon cancer	9.76e-05	0.00162	CcSEcCtD
Mifepristone—Headache—Methotrexate—colon cancer	9.71e-05	0.00161	CcSEcCtD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	9.68e-05	0.00237	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—LGR5—colon cancer	9.64e-05	0.00236	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—EP300—colon cancer	9.62e-05	0.00235	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1A—colon cancer	9.41e-05	0.0023	CbGpPWpGaD
Mifepristone—Nausea—Methotrexate—colon cancer	9.2e-05	0.00153	CcSEcCtD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	9e-05	0.0022	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9e-05	0.0022	CbGpPWpGaD
Mifepristone—ABCC1—Disease—LGR5—colon cancer	8.98e-05	0.0022	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CHST5—colon cancer	8.98e-05	0.0022	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—PPARG—colon cancer	8.96e-05	0.00219	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EGFR—colon cancer	8.92e-05	0.00218	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	8.91e-05	0.00218	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.67e-05	0.00212	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	8.56e-05	0.00209	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	8.56e-05	0.00209	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	8.55e-05	0.00209	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	8.48e-05	0.00207	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	8.43e-05	0.00206	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MYC—colon cancer	8.38e-05	0.00205	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—NRAS—colon cancer	8.37e-05	0.00205	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	8.36e-05	0.00204	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	8.15e-05	0.00199	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA7—colon cancer	7.83e-05	0.00191	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	7.65e-05	0.00187	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—EGFR—colon cancer	7.63e-05	0.00186	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	7.54e-05	0.00184	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CHST5—colon cancer	7.52e-05	0.00184	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ODC1—colon cancer	7.52e-05	0.00184	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	7.46e-05	0.00182	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	7.45e-05	0.00182	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	7.45e-05	0.00182	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	7.37e-05	0.0018	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—KRAS—colon cancer	7.21e-05	0.00176	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	7.19e-05	0.00176	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AXIN2—colon cancer	6.92e-05	0.00169	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—colon cancer	6.88e-05	0.00168	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	6.86e-05	0.00168	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	6.83e-05	0.00167	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	6.82e-05	0.00167	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—EP300—colon cancer	6.68e-05	0.00163	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PIK3CA—colon cancer	6.62e-05	0.00162	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CHST5—colon cancer	6.56e-05	0.0016	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ODC1—colon cancer	6.56e-05	0.0016	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	6.52e-05	0.00159	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	6.49e-05	0.00159	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AXIN2—colon cancer	6.45e-05	0.00158	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.34e-05	0.00155	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	6.33e-05	0.00155	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—AKT1—colon cancer	6.32e-05	0.00155	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CTNNB1—colon cancer	6.31e-05	0.00154	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HNF4A—colon cancer	6.28e-05	0.00153	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.17e-05	0.00151	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CDKN1A—colon cancer	6.16e-05	0.00151	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—colon cancer	6.13e-05	0.0015	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.11e-05	0.00149	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	6.07e-05	0.00148	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	5.99e-05	0.00146	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	5.97e-05	0.00146	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	5.97e-05	0.00146	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA7—colon cancer	5.91e-05	0.00144	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	5.84e-05	0.00143	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	5.68e-05	0.00139	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—PPARG—colon cancer	5.66e-05	0.00138	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	5.66e-05	0.00138	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA7—colon cancer	5.57e-05	0.00136	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	5.52e-05	0.00135	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	5.52e-05	0.00135	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	5.45e-05	0.00133	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	5.42e-05	0.00132	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—AKT1—colon cancer	5.41e-05	0.00132	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.38e-05	0.00132	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CASP3—colon cancer	5.24e-05	0.00128	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	5.17e-05	0.00126	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	5.13e-05	0.00125	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	5.12e-05	0.00125	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TGFB1—colon cancer	5.1e-05	0.00125	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	5.07e-05	0.00124	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	5e-05	0.00122	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.95e-05	0.00121	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.94e-05	0.00121	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	4.91e-05	0.0012	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.84e-05	0.00118	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	4.81e-05	0.00118	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.8e-05	0.00117	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HNF4A—colon cancer	4.78e-05	0.00117	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CHST5—colon cancer	4.74e-05	0.00116	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ODC1—colon cancer	4.74e-05	0.00116	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.57e-05	0.00112	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—colon cancer	4.44e-05	0.00109	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—PPARG—colon cancer	4.31e-05	0.00105	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	4.24e-05	0.00104	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.2e-05	0.00103	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	4.14e-05	0.00101	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—colon cancer	4.08e-05	0.000997	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.06e-05	0.000994	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.67e-05	0.000896	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA7—colon cancer	3.64e-05	0.00089	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HNF4A—colon cancer	3.63e-05	0.000887	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CHST5—colon cancer	3.58e-05	0.000875	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ODC1—colon cancer	3.58e-05	0.000875	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.43e-05	0.000839	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ODC1—colon cancer	3.37e-05	0.000825	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CHST5—colon cancer	3.37e-05	0.000825	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	3.27e-05	0.0008	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	3.27e-05	0.0008	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—colon cancer	3.23e-05	0.000789	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.11e-05	0.000759	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.78e-05	0.00068	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—colon cancer	2.73e-05	0.000666	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.58e-05	0.000632	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.52e-05	0.000615	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.49e-05	0.000609	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—colon cancer	2.46e-05	0.000601	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.44e-05	0.000597	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.43e-05	0.000595	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.32e-05	0.000566	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.25e-05	0.00055	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CHST5—colon cancer	2.21e-05	0.000539	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ODC1—colon cancer	2.21e-05	0.000539	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.19e-05	0.000536	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—colon cancer	2.08e-05	0.000508	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.03e-05	0.000497	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.02e-05	0.000493	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.01e-05	0.000492	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGFR3—colon cancer	2e-05	0.000489	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCB1—colon cancer	1.99e-05	0.000486	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.97e-05	0.000482	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TYMS—colon cancer	1.95e-05	0.000477	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	1.87e-05	0.000456	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.86e-05	0.000456	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR3—colon cancer	1.86e-05	0.000456	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—colon cancer	1.84e-05	0.000449	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—colon cancer	1.73e-05	0.000424	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—colon cancer	1.73e-05	0.000422	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.71e-05	0.000419	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—colon cancer	1.71e-05	0.000418	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMS—colon cancer	1.7e-05	0.000416	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.66e-05	0.000405	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—colon cancer	1.61e-05	0.000393	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—colon cancer	1.58e-05	0.000385	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—colon cancer	1.55e-05	0.00038	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.5e-05	0.000367	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.4e-05	0.000342	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—colon cancer	1.38e-05	0.000338	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—colon cancer	1.3e-05	0.000318	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—colon cancer	1.29e-05	0.000316	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—colon cancer	1.26e-05	0.000308	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—colon cancer	1.25e-05	0.000306	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—colon cancer	1.25e-05	0.000305	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—colon cancer	1.23e-05	0.000301	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—colon cancer	1.22e-05	0.000298	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—colon cancer	1.21e-05	0.000295	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—colon cancer	1.18e-05	0.000289	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—colon cancer	1.16e-05	0.000284	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—colon cancer	1.16e-05	0.000283	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—colon cancer	1.14e-05	0.000278	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—colon cancer	1.13e-05	0.000276	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—colon cancer	1.1e-05	0.000268	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—colon cancer	1.09e-05	0.000266	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—colon cancer	1.08e-05	0.000265	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—colon cancer	1.08e-05	0.000264	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—colon cancer	1.08e-05	0.000263	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—colon cancer	1.05e-05	0.000257	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—colon cancer	1.01e-05	0.000247	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—colon cancer	1.01e-05	0.000247	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—colon cancer	1.01e-05	0.000246	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—colon cancer	9.88e-06	0.000242	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—colon cancer	9.49e-06	0.000232	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—colon cancer	9.42e-06	0.00023	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—colon cancer	9.39e-06	0.00023	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—colon cancer	9.33e-06	0.000228	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—colon cancer	9.29e-06	0.000227	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—colon cancer	9.21e-06	0.000225	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—colon cancer	9.05e-06	0.000221	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—colon cancer	8.98e-06	0.00022	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—colon cancer	8.91e-06	0.000218	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—colon cancer	8.75e-06	0.000214	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—colon cancer	8.72e-06	0.000213	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—colon cancer	8.7e-06	0.000213	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—colon cancer	8.58e-06	0.00021	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—colon cancer	8.3e-06	0.000203	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—colon cancer	8.21e-06	0.000201	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—colon cancer	7.99e-06	0.000195	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—colon cancer	7.93e-06	0.000194	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—colon cancer	7.89e-06	0.000193	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—colon cancer	7.4e-06	0.000181	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—colon cancer	7.01e-06	0.000171	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—colon cancer	6.86e-06	0.000168	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—colon cancer	6.69e-06	0.000164	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—colon cancer	6.58e-06	0.000161	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—colon cancer	6.53e-06	0.00016	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—colon cancer	6.23e-06	0.000152	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—colon cancer	6.2e-06	0.000152	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—colon cancer	5.84e-06	0.000143	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—colon cancer	5.83e-06	0.000142	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—colon cancer	5.72e-06	0.00014	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—colon cancer	5.71e-06	0.000139	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—colon cancer	5.47e-06	0.000134	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—colon cancer	5.18e-06	0.000127	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—colon cancer	4.88e-06	0.000119	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—colon cancer	4.77e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—colon cancer	4.31e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—colon cancer	4.22e-06	0.000103	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—colon cancer	4.06e-06	9.92e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—colon cancer	4.05e-06	9.91e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—colon cancer	3.45e-06	8.43e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—colon cancer	3.19e-06	7.8e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—colon cancer	3.18e-06	7.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—colon cancer	3e-06	7.34e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—colon cancer	2.65e-06	6.48e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—colon cancer	2.6e-06	6.36e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—colon cancer	2.45e-06	5.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—colon cancer	1.96e-06	4.8e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—colon cancer	1.6e-06	3.92e-05	CbGpPWpGaD
